Whitehawk Therapeutics, Inc. ·
WHWK 8-K 2026-09-10
Whitehawk Therapeutics, Inc. (WHWK) 8-K dated 2026-09-10 — accession 0001193125-26-388010. This URL is the filing, not the WHWK hub.
Whitehawk Therapeutics, Inc. (WHWK) is a biotechnology company listed on NASDAQ.
Whitehawk Therapeutics, Inc. filed a 8-K on 2026-09-10. Accession 0001193125-26-388010.
Cached items: 5.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.
Latest reported WHWK revenue for 2025-12-31 was $7.1M. Net income was -$20.6M. Revenue was down 72.5% from 2024-12-31 to 2025-12-31. WHWK currently screens at market cap $202.8M.
Not investment advice. The WHWK SEC hub lists recent forms. The stock page is the research view.